Bradykinin antagonists: new opportunities

被引:50
作者
Bock, MG [1 ]
Longmore, J
机构
[1] Merck Res Labs, W Point, PA 19486 USA
[2] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
关键词
D O I
10.1016/S1367-5931(00)00107-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pro-inflammatory, pain producing, and cardiovascular effects of bradykinin B-2 receptor activation are well characterized. Bradykinin B-1 receptors also produce inflammation and pain. Therefore, antagonists are expected to be anti-inflammatory/analgesic drugs. Other exploitable clinical opportunities may exist. The newly discovered non-peptide B-2 receptor antagonists and the equivalent B-1 receptor pharmacological agents, which are in the pipeline, are suitable preclinical tools to properly evaluate potential utilities.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 37 条
  • [1] Inflammatory mediators and modulation of blood-brain barrier permeability
    Abbott, NJ
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2000, 20 (02) : 131 - 147
  • [2] B1 receptors as a new inflammatory target.: Could this B the 1?
    Ahluwalia, A
    Perretti, M
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (03) : 100 - 104
  • [3] AMBIARD M, 1999, P 15 AM PEPT S 1997, P100
  • [4] Discovery of orally active nonpeptide bradykinin B2 receptor antagonists
    Asano, M
    Inamura, N
    Hatori, C
    Sawai, H
    Fujiwara, T
    Abe, Y
    Kayakiri, H
    Satoh, S
    Oku, T
    Nakahara, K
    [J]. IMMUNOPHARMACOLOGY, 1999, 43 (2-3): : 163 - 168
  • [5] Inflammatory hyperalgesia induced by zymosan in the plantar tissue of the rat:: effect of kinin receptor antagonists
    Bélichard, P
    Landry, M
    Faye, P
    Bachvarov, DR
    Bouthillier, J
    Pruneau, D
    Marceau, F
    [J]. IMMUNOPHARMACOLOGY, 2000, 46 (02): : 139 - 147
  • [6] Bradyzide, a potent non-peptide B2 bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia
    Burgess, GM
    Perkins, MN
    Rang, HP
    Campbell, EA
    Brown, MC
    McIntyre, P
    Urban, L
    Dziadulewicz, EK
    Ritchie, TJ
    Hallett, A
    Snell, CR
    Wrigglesworth, R
    Lee, W
    Davis, C
    Phagoo, SB
    Davis, AJ
    Phillips, E
    Drake, GS
    Hughes, GA
    Dunstan, A
    Bloomfield, GC
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (01) : 77 - 86
  • [7] CESARE P, 2000, LIFE SCI, V307, P100
  • [8] Choo HYP, 1999, BIOORG MED CHEM LETT, V9, P2727
  • [9] Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure
    Davie, AP
    Dargie, HJ
    McMurray, JJV
    [J]. CIRCULATION, 1999, 100 (03) : 268 - 273
  • [10] Bradykinin in the heart - Friend or foe?
    Dell'Italia, LJ
    Oparil, S
    [J]. CIRCULATION, 1999, 100 (23) : 2305 - 2307